VNDA
Vanda Pharmaceuticals Inc
Price:  
4.80 
USD
Volume:  
932,173.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA Relative Valuation

-119.4%
Upside

As of 2025-02-09, the Relative Valuation of Vanda Pharmaceuticals Inc (VNDA) is (0.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.80 USD, the upside of Vanda Pharmaceuticals Inc based on Relative Valuation is -119.4%.

The range of the Relative Valuation is (2.46) - 3.66 USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 8.8x - 26.1x 14.6x
Forward P/E multiples 16.3x - 40.1x 24.4x
Fair Price (2.46) - 3.66 (0.93)
Upside -151.3% - -23.8% -119.4%
4.80 USD
Stock Price
(0.93) USD
Fair Price

VNDA Relative Valuation - Historical P/E Data

Date P/E
2025-02-07 -17.08
2025-02-06 -16.69
2025-02-05 -16.12
2025-02-04 -15.94
2025-02-03 -15.34
2025-01-31 -15.69
2025-01-30 -16.30
2025-01-29 -16.12
2025-01-28 -15.80
2025-01-27 -15.83
2025-01-24 -15.66
2025-01-23 -15.73
2025-01-22 -15.48
2025-01-21 -16.05
2025-01-17 -15.51
2025-01-16 -15.80
2025-01-15 -15.83
2025-01-14 -15.58
2025-01-13 -16.12
2025-01-10 -16.37
2025-01-08 -16.55
2025-01-07 -17.26
2025-01-06 -17.04
2025-01-03 -17.26
2025-01-02 -17.15
2024-12-31 -17.04
2024-12-30 -17.01
2024-12-27 -17.11
2024-12-26 -17.11
2024-12-24 -17.19
2024-12-23 -16.65
2024-12-20 -17.01
2024-12-19 -16.47
2024-12-18 -16.19
2024-12-17 -16.83
2024-12-16 -16.47
2024-12-13 -16.40
2024-12-12 -16.44
2024-12-11 -16.62
2024-12-10 -16.37
2024-12-09 -17.15
2024-12-06 -17.22
2024-12-05 -17.01
2024-12-04 -17.22
2024-12-03 -17.47
2024-12-02 -17.93
2024-11-29 -18.32
2024-11-27 -18.47
2024-11-26 -17.72
2024-11-25 -17.97